First North Dakota Quarterly Drug Price Transparency Reports Due in October
FDA Law Blog
SEPTEMBER 12, 2021
Schlanger — Earlier this year, North Dakota enacted a prescription drug price transparency reporting law, HB 1032 , that became effective on August 1, 2021. The quarterly WAC reports submitted in October will be made available on the North Dakota Insurance Department’s Prescription Drug Cost Transparency website.
Let's personalize your content